Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Indian Inst. of Technology Madras hNNMT compound 7b: sourced facts only. name: "The MOA studies suggest that compound 7b functions as a bisubstrate competitive inhibitor of hNNMT, exhibiting competitive inhibition with respect to both SAM and quinoline, without altering Vmax." [PMID:40961781]; target: "The MOA studies suggest that compound 7b functions as a bisubstrate competitive inhibitor of hNNMT, exhibiting competitive inhibition with respect to both SAM and quinoline, without altering Vmax." [PMID:40961781]; developer: "Chemical Biology Laboratory, Bhupat and Jyoti Mehta School of Biosciences, Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India." [PMID:40961781]; stage: "Furthermore, cellular assays showed that compounds 7b, 7c, and 7d selectively suppressed the proliferation of U87 and PANC-1 cancer cells, and low cytotoxicity in HEK293 normal cell lines." [PMID:40961781]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Indian Inst. of Technology Madras hNNMT compound 7b.